Transplantation
Interferon therapy prior to liver transplant curbs hepatitis C recurrence
Published in Blood Weekly, October 30th, 2003
According to published research from the United States, "an analysis of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplant Registry data shows that the greater the viral load at the time of transplantation, the more rapidly clinically evident post-transplantation hepatitis C virus (HCV) disease recurs. These data suggest that aggressive pretransplantation treatment of HCV might delay recurrent posttransplantation HCV disease and enhance posttransplantation survival. We have taken an aggressive approach to treating HCV infection pretransplantation with the use of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-10-30)
More Articles from Blood Weekly
- Stem-Cell Transplantation
Costimulation blockade induces hematopoietic chimerism, central tolerance in SCT patients - Stem-Cell Transplantation
Rituximab active against refractory chronic GVHD - Myeloma Therapy
Treosulfan shows promise for multiple myeloma treatment - Stem-Cell Research
A58 oncogene can immortalize hematopoietic cells - Stem-Cell Research
Hematopoietic and mature blood cells can differentiate into cardiomyocytes - Transfusion Medicine
Dipyridamole improves efficacy of plasma exchange in TTP patients - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
